ChromaDex Corp.
Nicotinamide riboside (NR) ingredient called Niagen® for NAD+ enhancement
New patent ·
- Sector
- Biotech
- Headquarters
- Los Angeles, CA
- Founded
- 2008
- Latest Form D
- $3.1M, Oct 2022
- Total capital
- $110M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $110M
- 15 Form D · last Oct 2022
- 48 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- first 2026
- Rank in peer group#481 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 15th filing$3.1M
- Private capital raisedForm D · SEC · 14th filing$25M
- Private capital raisedForm D · SEC · 13th filing$5M
- Private capital raisedForm D · SEC · 12th filing$7M
- Private capital raisedForm D · SEC · 11th filing$10M
- Private capital raisedForm D · SEC · 10th filing$23M
- Private capital raisedForm D · SEC · 9th filing$5.1M
- Private capital raisedForm D · SEC · 8th filing$16.4M
- Private capital raisedForm D · SEC · 7th filing$3.5M
- Private capital raisedForm D · SEC · 6th filing$1M
- Private capital raisedForm D · SEC · 5th filing$500K
- Private capital raisedForm D · SEC · 4th filing$445K
- Private capital raisedForm D · SEC · 3rd filing$3M
- Private capital raisedForm D · SEC · 2nd filing$3.7M
- Private capital raisedForm D · SEC · 1st filing$3.7M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#481 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Ann N. CohenDirectorNamed in SEC Form D filings
- Barry HonigDirectorNamed in SEC Form D filings
- Brianna N. GerberExecutive OfficerNamed in SEC Form D filings
- Curtis A. LockshinDirectorNamed in SEC Form D filings
- Frank JakschExecutive Officer, DirectorNamed in SEC Form D filings
- Frank L. Jaksch, Jr.Executive Officer, DirectorNamed in SEC Form D filings
Show all 40 people
- Frank, Jr. JakschExecutive Officer, DirectorNamed in SEC Form D filings
- Gary N. NgDirectorNamed in SEC Form D filings
- Glenn L. HalprynDirectorNamed in SEC Form D filings
- Hamed N. ShahbaziDirectorNamed in SEC Form D filings
- Hugh 10005 Muirlands Blvd., Suite G DunkerleyDirectorNamed in SEC Form D filings
- Hugh C. DunkerlyDirectorNamed in SEC Form D filings
- Jeff L. BaxterDirectorNamed in SEC Form D filings
- Jeffrey HimmelExecutive Officer, DirectorNamed in SEC Form D filings
- Kevin M. FarrExecutive OfficerNamed in SEC Form D filings
- Kristin N. PatrickDirectorNamed in SEC Form D filings
- Kurt L. GustafsonDirectorNamed in SEC Form D filings
- Lisa M. BratkovichExecutive OfficerNamed in SEC Form D filings
- Mark L. FriedmanExecutive OfficerNamed in SEC Form D filings
- Mark S. GermainDirectorNamed in SEC Form D filings
- Mark D P GermaineDirectorNamed in SEC Form D filings
- Matthew M. RobertsExecutive OfficerNamed in SEC Form D filings
- Megan JordanExecutive OfficerNamed in SEC Form D filings
- Michael BrauserDirectorNamed in SEC Form D filings
- Reid J D DabneyDirectorNamed in SEC Form D filings
- Robert FriedExecutive Officer, DirectorNamed in SEC Form D filings
- Rob 10005 Muirlands Blvd., Suite G FriedDirectorNamed in SEC Form D filings
- Stephen L. AllenDirectorNamed in SEC Form D filings
- Stephen A. BlockDirectorNamed in SEC Form D filings
- Steve L. AllenDirectorNamed in SEC Form D filings
- Steven 10005 Muirlands Blvd., Suite G BlockDirectorNamed in SEC Form D filings
- Steven L. RubinDirectorNamed in SEC Form D filings
- Thomas L. VarvaroExecutive OfficerNamed in SEC Form D filings
- Tom 10005 Muirlands Blvd., Suite G VarvaroExecutive OfficerNamed in SEC Form D filings
- Tony LauDirectorNamed in SEC Form D filings
- Troy L. RhonemusExecutive OfficerNamed in SEC Form D filings
- Troy ThonemusExecutive OfficerNamed in SEC Form D filings
- Tsz Ho Tony L. LauDirectorNamed in SEC Form D filings
- Wendy YuDirectorNamed in SEC Form D filings
- Wing Tak Wendy L. YuDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 1- New patentMethods Of Preparing Reduced Nicotinamide Riboside And Derivatives ThereofUSPTOUS 12,760,055
Related companies, and why
- aTYR PHARMA INCSimilar federal contract value in Biotech · null in contracts
- Liberation Bioindustries, Inc.Similar federal contract value in Biotech · null in contracts
- EDITAS MEDICINE, INC.Similar federal contract value in Biotech · null in contracts
- Amphista TherapeuticsSimilar federal contract value in Biotech · null in contracts
- REGENNOVA, INC.Similar federal contract value in Biotech · null in contracts
- DTx Pharma, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .